Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.
Prentice, Ross L
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. [electronic resource] - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Nov 2009 - 3079-85 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1538-7755
10.1158/1055-9965.EPI-09-0611 doi
Aged
Biomarkers, Tumor--genetics
Breast Neoplasms--diagnosis
Case-Control Studies
Cohort Studies
Estrogen Replacement Therapy
Estrogens--therapeutic use
Female
Genotype
Humans
Introns--genetics
Linkage Disequilibrium
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Polymorphism, Single Nucleotide--genetics
Postmenopause--genetics
Progestins--therapeutic use
Prognosis
Receptor, Fibroblast Growth Factor, Type 2--genetics
Risk Factors
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. [electronic resource] - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Nov 2009 - 3079-85 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1538-7755
10.1158/1055-9965.EPI-09-0611 doi
Aged
Biomarkers, Tumor--genetics
Breast Neoplasms--diagnosis
Case-Control Studies
Cohort Studies
Estrogen Replacement Therapy
Estrogens--therapeutic use
Female
Genotype
Humans
Introns--genetics
Linkage Disequilibrium
Middle Aged
Neoplasm Invasiveness
Neoplasm Staging
Polymorphism, Single Nucleotide--genetics
Postmenopause--genetics
Progestins--therapeutic use
Prognosis
Receptor, Fibroblast Growth Factor, Type 2--genetics
Risk Factors